Clinical Nutrition for Diabetes Care Market Analysis

Clinical Nutrition for Diabetes Care Market Analysis

Based on product, the market is segmented into oral nutrition, parenteral nutrition, and enteral feeding formulas. The oral nutrition segment is further divided into ready-to-use and not ready-to-use. The ready-to-use segment is further sub-segmented into liquids and solids.
 

• The oral nutrition segment accounted for significant market share of 65.2% in 2023.
   
• Oral nutritional products tend to be more cost-effective than parenteral or enteral nutrition. They are often more affordable and accessible, making them a preferred choice for both patients and healthcare systems, thereby solidifying its position.
   
• These products are generally more acceptable and palatable to patients compared to other forms of clinical nutrition. Thus, the ease of consumption and higher palatability contributes to the growth of this segment.
   
• Furthermore, wide variety of products, balanced nutritional content, and strong market demand supports the growth of the segment.
   

Based on disease type, the clinical nutrition for diabetes care market is classified into type 2 diabetes and type 1 diabetes. The type 2 diabetes segment dominated the market and was valued at USD 1.6 billion in 2023.
 

• According to World Health Organization 2023, more than 90-95% of people with diabetes have type 2 diabetes worldwide. This higher prevalence significantly increases the demand for clinical nutrition products tailored to manage this type.
   
• Type 2 diabetes management heavily relies on lifestyle modifications, including dietary changes. Clinical nutrition products designed for such patients are integral to effective disease management.
   
• Thus, the aforementioned factors drive the growth of type 2 diabetes segment in this market.
   

Based on consumer, the clinical nutrition for diabetes care market is divided into adult and pediatric. The adult segment dominated the market in 2023 and is anticipated to grow at 4.6% of CAGR over the forecast period.
 

• As per the IDF Diabetes Atlas (2021), approximately 10.5% of overall adult population (20 – 79 years) across the world has diabetes. This age group experiences higher rates of diabetes due to factors such as aging, lifestyle changes, and increased incidence of obesity.
   
• As a result, the demand for clinical nutrition products tailored to adults is significantly higher.
   
• Furthermore, this demographic is more likely to seek out and adhere to clinical nutrition solutions as part of their diabetes care regimen. Thus, the increased awareness drives demand for these products.
   

Based on dosage form, the clinical nutrition for diabetes care market is categorized into powder, liquid, and solid. The powder segment held highest market share and is predicted to reach USD 1.8 billion by the end of the analysis timeframe.
 

• Powdered nutritional products typically have a longer shelf life compared to liquid formulations. This makes them more convenient for storage and distribution, thereby fostering the growth of this segment.
   
• Additionally, widespread availability and accessibility of powder products contributes to their higher market share as more diabetic patients opt for these products due to convenience and availability.
   
• Moreover, factors such as versatility, cost-effectiveness, increased patient preference, and improved taste supports the growth of this segment.
   

Based on distribution channel, the clinical nutrition for diabetes care market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and other distribution channels. The retail pharmacies segment is poised to grow at 4.6% CAGR and reach USD 1.4 billion by 2032.
 

• Retail pharmacies offer convenient access to clinical nutrition products for diabetes management and have a widespread network of outlets.
   
• Further, increased availability of clinical nutrition products over-the-counter significantly drives the growth of retail pharmacies allowing diabetic patients to easily access these products.
   
• These factors collectively contribute to the growth of this segment.
   

North America clinical nutrition for diabetes care market size accounted for USD 922.1 million in 2023 and is anticipated to grow at 4.6% CAGR between 2024 - 2032.
 

• North America has a significant prevalence of diabetes, which drives the demand for clinical nutrition products designed for diabetes management. For instance, as per the American Diabetes Association, approximately 38.4 million Americans, or 11.6% of the population had diabetes in 2021.
   
• Moreover, North America has one of the highest healthcare expenditures globally, with significant investments in diabetes management and related healthcare services. This financial commitment supports the availability and affordability of clinical nutrition products within the market.
   

The U.S. clinical nutrition for diabetes care market is projected to witness growth at 4.5% CAGR to reach USD 1.2 billion by 2032.
 

• The U.S. boasts a sophisticated healthcare infrastructure with well-established healthcare facilities, including hospitals, clinics, and pharmacies. This infrastructure supports widespread access to clinical nutrition products across the country, facilitating their distribution and availability.
   
• Additionally, a high level of consumer awareness about diabetes management in the U.S., driven by extensive healthcare education initiatives, further fuel the demand for clinical nutrition products.
   

Germany clinical nutrition for diabetes care market is anticipated to experience lucrative growth in coming years.
 

• Growing emphasis on preventive healthcare measures, including early intervention and management of chronic conditions like diabetes has significantly driven the adoption of clinical nutrition products to manage conditions like diabetes.
   
• Additionally, presence of leading healthcare companies and manufacturers in Germany fosters strong market competition and promotes innovation in clinical nutrition products. This competitive landscape drives continuous improvement in product quality, affordability, and accessibility for diabetic patients in the country, thereby fostering market growth.
   

India clinical nutrition for diabetes care market is poised to showcase lucrative growth over the analysis period.
 

• According to World Health Organization, in India there are estimated 77 million people above the age of 18 years suffering from diabetes and nearly 25 million are prediabetics.
   
• This large and growing diabetes and prediabetes patient population underscores the increasing demand for specialized nutritional products aimed at managing blood glucose levels and preventing complications associated with diabetes.